CLINICAL_TRIALS
trial_result
· 2020-07-01
Clinical Trial Update: Study of Eteplirsen in DMD Patients [Phase 3]
Summary
Phase 3 trial evaluating eteplirsen in Duchenne Muscular Dystrophy has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sarepta Therapeutics, Inc. | Conditions: Duchenne Muscular Dystrophy (DMD) | Phase 3 | Status: COMPLETED | Results posted: 2020-07-01